Cite this article as: Pandya NR, Daley M, Mattke A, Shikata F, Betts K, Haisz E et al. A comparison of pump-controlled retrograde trial off to arterio-venous bridging for weaning from venoarterial extracorporeal membrane oxygenation. Eur J Cardiothorac Surg 2019;56:277–84. A comparison of pump-controlled retrograde trial off to arterio-venous bridging for weaning from venoarterial extracorporeal membrane oxygenation† Nischal R. Pandya a,b , Michael Daley a , Adrian Mattke b,c,d , Fumiaki Shikata a,b , Kim Betts e , Emma Haisz c,d , Anthony Black f , Benjamin Anderson b,g , Nelson Alphonso a,b and Prem Venugopal a,b, * a Department of Cardiac Surgery, Lady Cilento Children’s Hospital, Brisbane, Australia b School of Medicine, University of Queensland, Brisbane, Australia c Pediatric Intensive Care Unit, Lady Cilento Children’s Hospital, Brisbane, Australia d Pediatric Critical Care Research Group, Mater Mother’s Research Institute, Brisbane, Australia e Department of Epidemiology, Institute for Social Science Research, University of Queensland, Brisbane, Australia f Cardiac Surgery (Perfusion), Lady Cilento Children’s Hospital, Brisbane, Australia g Department of Cardiology, Lady Cilento Children’s Hospital, Brisbane, Australia * Corresponding author. Department of Cardiac Surgery, Lady Cilento Children’s Hospital, PO Box 3474, Level 7F, 501 Stanley Street, South Brisbane, QLD 4101, Australia. Tel: +61-7-30685775; fax: +61-7-30683169; e-mail: vpremsundar@hotmail.com (P. Venugopal). Received 18 September 2018; received in revised form 10 December 2018; accepted 21 December 2018 Abstract OBJECTIVES: The aim of the study is to compare a technique of pump-controlled retrograde trial off (PCRTO) to insertion of an arterio- venous (AV) bridge to conduct a trial from venoarterial extracorporeal membrane oxygenation (VA ECMO). METHODS: We studied all patients who were weaned from VA ECMO using either PCRTO or AV bridging from November 2014 to April 2018. Demographic data, indications for ECMO, duration of ECMO, duration of trial period off ECMO and survival were compared be- tween the 2 groups. †Presented at the 32nd Annual Meeting of the European Association for Cardio-Thoracic Surgery, Milan, Italy, 18–20 October 2018. TX & MCS VC The Author(s) 2019. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved. European Journal of Cardio-Thoracic Surgery 56 (2019) 277–284 ORIGINAL ARTICLE doi:10.1093/ejcts/ezy485 Advance Access publication 29 January 2019 Downloaded from https://academic.oup.com/ejcts/article/56/2/277/5303951 by guest on 09 June 2022